CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate
Ovarian cancer is a leading cause of death from gynecologic malignancies worldwide. Although CD83 is widely described as a solid marker for mature dendritic cells, emerging pieces of evidence indicate the expression of membrane protein CD83 by various tumor cells, including ovarian cancer cells. How...
Main Authors: | Aalia Batool, Hao Liu, Yi-Xun Liu, Su-Ren Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2269 |
Similar Items
-
HMGB3 promotes the malignant phenotypes and stemness of epithelial ovarian cancer through the MAPK/ERK signaling pathway
by: Hanlin Ma, et al.
Published: (2023-06-01) -
Copine 7 promotes colorectal cancer proliferation through PKM2 interaction and MAPK signaling pathway
by: Tianwen Yu, et al.
Published: (2023-07-01) -
CD83 Regulates the Immune Responses in Inflammatory Disorders
by: Bushra Riaz, et al.
Published: (2023-02-01) -
Soluble CD83 modulates human-monocyte-derived macrophages toward alternative phenotype, function, and metabolism
by: Katrin Peckert-Maier, et al.
Published: (2023-12-01) -
Decreased CD1a + and CD83 + cells in tonsillar squamous cell carcinoma regardless of HPV status
by: Ana Guadalupe Gama-Cuellar, et al.
Published: (2022-05-01)